Align Technology: DCF Signals Overvaluation Despite Long-Term Growth Potential
SeekingAlpha18 days agoALGN
1 Cash-Producing Stock Worth Your Attention and 2 That Underwhelm
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Yahoo21 days agoALGN
Is NVST a Buy as Earnings Rebound but Valuation Remains Above Median?
Envista's earnings rebound and raised 2026 guidance strengthen the case, but above-median valuation leaves less room for execution setbacks.
Yahoo22 days agoALGN
Align Technology (NASDAQ:ALGN): A Value Stock with Strong Fundamentals
Align Technology (ALGN) appears undervalued with strong profitability, no debt, and decent growth, fitting the Decent Value screen.
ChartMill22 days agoALGN
Align Technology Prevails in China Patent Infringement Action
Align Technology (ALGN) disclosed late Tuesday that the Jinan Intermediate People's Court in China i
Yahoo23 days agoALGN
Align Technology Prevails in China Patent Infringement Action Against Angelalign
SAN JOSE, Calif. & TEMPE, Ariz., August 12, 2026--Align Technology, Inc. ("Align") (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, today announced that the Jinan Intermediate People's Court in China issued a judgment in favor of Align in a patent infringement action against Angelalign Technology's operating subsidiaries in China ("Angel") (Hong Kong Stock Exchange: 6699.HK).
Yahoo23 days agoALGN
Align Technology (ALGN) Q2 2026 Earnings Call Transcript
Clear aligner volumes hit record levels amid $37.5 million UK VAT liability.
Yahoo27 days agoALGN
Align Technology: A Structurally Better Business Trading At A Structurally Lower Multiple
Align Technology delivers record revenue, volume, and operating margins, yet trades near five-year valuation lows. Read more on ALGN stock here.
SeekingAlpha28 days agoALGN
Can Segment Strength Offset Headwinds for BD Stock Before Q3 Earnings?
BDX's Medical Essentials and Interventional strength may drive third-quarter fiscal 2026 results, but China, vaccines and projected declines weigh on expectations.
Yahoo29 days agoALGN
ALGN Q2 Deep Dive: Clear Aligner Volumes Grow, Guidance Flags Scanner Mix Shift
Dental technology company Align Technology (NASDAQ:ALGN) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 4.3% year on year to $1.06 billion. On the other hand, next quarter’s revenue guidance of $1.01 billion was less impressive, coming in 1.3% below analysts’ estimates. Its non-GAAP profit of $2.64 per share was 1.7% above analysts’ consensus estimates.
Yahoolast monthALGN